Distinguishing Bipolar from Unipolar Depression
The Carlat Psychiatry Report, Volume 9, Number 1, January 2011
Ross Baldessarini, MD
Professor of psychiatry and neuroscience, Harvard Medical School, Boston, MA; Director, psychopharmacology program & International Consortium for Bipolar Disorder Research, McLean Hospital, Belmont, MA
Dr. Baldessarini has disclosed that he has recently been a paid consultant to Alkermes, Inc., a comarketer of Risperdal Consta and VIVITROL (a monthly injectable form of naloxone for alcohol and opioid dependence). Dr. Carlat reviewed this article and found that there is no evidence of commercial bias in this educational activity.
Some patients complain bitterly about depression and dysphoria, but they don’t tell you anything about the other half of their lives—the upswings of mood and energy—so you may not realize the need to suspect bipolar illness.